Microsatellite instability status in metastatic colorectal cancer and effect of immune checkpoint inhibitors on survival in MSI-high metastatic colorectal cancer

被引：0

作者：

Okamoto, W. ^{[1
]}

Nakamura, Y. ^{[2
]}

Shiozawa, M. ^{[3
]}

Komatsu, Y. ^{[4
]}

Denda, T. ^{[5
]}

Hara, H. ^{[6
]}

Kagawa, Y. ^{[7
]}

Narita, Y. ^{[8
]}

Kawakami, H. ^{[9
]}

Esaki, T. ^{[10
]}

Nishina, T. ^{[11
]}

Izawa, N. ^{[12
]}

Ando, K. ^{[13
]}

Moriwaki, T. ^{[14
]}

Kato, T. ^{[15
]}

Nagashima, F. ^{[16
]}

Satoh, T. ^{[17
]}

Nomura, S. ^{[18
]}

Yoshino, T. ^{[2
]}

Akagi, K. ^{[19
]}

机构：

[1] Hiroshima Univ Hosp, Canc Treatment Ctr, Hiroshima, Japan

[2] Natl Canc Ctr Hosp East, Dept Gastroenterol & Gastrointestinal Oncol, Kashiwa, Chiba, Japan

[3] Kanagawa Canc Ctr, Gastrointestinal Surg, Yokohama, Kanagawa, Japan

[4] Hokkaido Univ Hosp, Dept Canc Chemotherapy, Canc Ctr, Sapporo, Hokkaido, Japan

[5] Chiba Canc Ctr Hosp, Div Gastroenterol, Chiba, Japan

[6] Saitama Canc Ctr, Dept Gastroenterol, Saitama, Japan

[7] Kansai Rosai Hosp, Surg, Amagasaki, Hyogo, Japan

[8] Aichi Canc Ctr Hosp, Dept Clin Oncol, Nagoya, Aichi, Japan

[9] Kindai Univ, Dept Med Oncol, Fac Med, Osaka, Japan

[10] Natl Kyushu Canc Ctr, Dept Gastrointestinal & Med Oncol, Fukuoka, Fukuoka, Japan

[11] Shikoku Canc Ctr, Dept Gastrointestinal Med Oncol, Matsuyama, Ehime, Japan

[12] St Marianna Univ, Clin Oncol, Sch Med, Kawasaki, Kanagawa, Japan

[13] Kyushu Univ, Surg & Sci, Fukuoka, Fukuoka, Japan

[14] Univ Tsukuba, Gastroenterol, Fac Med, Tsukuba, Ibaraki, Japan

[15] Osaka Natl Hosp, Dept Surg, Osaka, Japan

[16] Kyorin Univ Hosp, Med Oncol, Tokyo, Japan

[17] Osaka Univ, Fac Med, Grad Sch Med, Dept Frontier Sci Canc & Chemotherapy, Suita, Osaka, Japan

[18] Natl Canc Ctr Hosp East, Clin Res Support Off, Kashiwa, Chiba, Japan

[19] Saitama Canc Ctr, Mol Diag & Canc Prevent, Saitama, Japan

来源：

ANNALS OF ONCOLOGY | 2019年 / 30卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

614P

引用

页数：2

共 50 条

[21] Microsatellite instability in metastatic colorectal cancer (mCRC)
Kim, Jee Hung
Kim, Chang-gon
Ahn, Joong Bae
Jung, MinKyu
Beom, Seung Hoon
Kim, Joo Hoon
Heo, Soo Jin
Shin, Sang Joon
CANCER RESEARCH, 2016, 76
[22] Inflammation promotes resistance to immune checkpoint inhibitors in high microsatellite instability colorectal cancer
Qiaoqi Sui
Xi Zhang
Chao Chen
Jinghua Tang
Jiehai Yu
Weihao Li
Kai Han
Wu Jiang
Leen Liao
Lingheng Kong
Yuan Li
Zhenlin Hou
Chi Zhou
Chenzhi Zhang
Linjie Zhang
Binyi Xiao
Weijian Mei
Yanbo Xu
Jiayi Qin
Jian Zheng
Zhizhong Pan
Pei-Rong Ding
Nature Communications, 13
[23] Inflammation promotes resistance to immune checkpoint inhibitors in high microsatellite instability colorectal cancer
Sui, Qiaoqi
Zhang, Xi
Chen, Chao
Tang, Jinghua
Yu, Jiehai
Li, Weihao
Han, Kai
Jiang, Wu
Liao, Leen
Kong, Lingheng
Li, Yuan
Hou, Zhenlin
Zhou, Chi
Zhang, Chenzhi
Zhang, Linjie
Xiao, Binyi
Mei, Weijian
Xu, Yanbo
Qin, Jiayi
Zheng, Jian
Pan, Zhizhong
Ding, Pei-Rong
NATURE COMMUNICATIONS, 2022, 13 (01)
[24] Nivolumab in the treatment of microsatellite instability high metastatic colorectal cancer
Sarshekeh, Amir Mehrvarz
Overman, Michael J.
Kopetz, Scott
FUTURE ONCOLOGY, 2018, 14 (18) : 1868 - 1874
[25] Pseudoprogression in patients treated with immune checkpoint inhibitors for microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer
Colle, Raphael
Radzik, Anna
Cohen, Romain
Pellat, Anna
Lopez-Tabada, Daniel
Cachanado, Marine
Duval, Alex
Svrcek, Magali
Menu, Yves
Andre, Thierry
EUROPEAN JOURNAL OF CANCER, 2021, 144 : 9 - 16
[26] Early treatment discontinuation in patients with deficient mismatch repair or microsatellite instability high metastatic colorectal cancer receiving immune checkpoint inhibitors
Taieb, Julien
Ambrosini, Margherita
Alouani, Emily
Lonardi, Sara
Sinicrope, Frank A.
Decraecker, Marie
Boileve, Alice
Hafliger, Emilie
Mazard, Thibault
Pernot, Simon
Parent, Pauline
Ros, Javier
Overman, Michael J.
Jayachandran, Priya
Nasca, Vincenzo
Salvatore, Lisa
Guimbaud, Rosine
Cremolini, Chiara
Tougeron, David
Pietrantonio, Filippo
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2025, 13 (01)
[27] Cost-effectiveness of immune checkpoint inhibitors for microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer
Chu, Jacqueline N.
Choi, Jin
Ostvar, Sassan
Torchia, James A.
Reynolds, Kerry Lynn
Tramontano, Angela
Gainor, Justin F.
Chung, Daniel C.
Clark, Jeffrey W.
Hur, Chin
CANCER, 2019, 125 (02) : 278 - 289
[28] Acute Ulceronecrotic Gastritis With Cytomegalovirus Reactivation: Uncommon Toxicity of Immune Checkpoint Inhibitors in Microsatellite Instability-High Metastatic Colorectal Cancer
Hulo, Pauline
Touchefeu, Yann
Cauchin, Estelle
Archambeaud, Isabelle
Chapelle, Nicolas
Bossard, Celine
Bennouna, Jaafar
CLINICAL COLORECTAL CANCER, 2020, 19 (04) : E183 - E188
[29] Treatment with checkpoint inhibitors in a metastatic colorectal cancer patient with molecular and immunohistochemical heterogeneity in MSI/dMMR status
Loupakis, Fotios
Maddalena, Giulia
Depetris, Ilaria
Murgioni, Sabina
Bergamo, Francesca
Dei Tos, Angelo Paolo
Rugge, Massimo
Munari, Giada
Nguyen, Andrew
Szeto, Christopher
Zagonel, Vittorina
Lonardi, Sara
Fassan, Matteo
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7 (01)
[30] Impact of microsatellite instability (MSI) on tumor clonal evolution in metastatic colorectal cancer (mCRC).
Willis, Jason
Morelli, Maria Pia
Morris, Van Karlyle
Loree, Jonathan
Lam, Michael
Pereira, Allan Andresson Lima
Raghav, Kanwal Pratap Singh
Kee, Bryan K.
Sanchez, Eduardo Vilar
Eng, Cathy
Manuel, Shanequa
Crosby, Shadarra
Wolff, Robert A.
Lanman, Richard B.
Talasaz, AmirAli
Janku, Filip
Overman, Michael J.
Kopetz, Scott
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)

← 1 2 3 4 5 →